BKB GROWTH INVESTMENTS, LLC enters VERRICA PHARMACEUTICALS INC. with 3.35M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/26/2026ACC: 0002101167-26-000002
10% Owner
Since Nov 2025
3.35M
Baseline shares
100% direct
3.35M
Direct ownership
1 position
912.41K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3.35M
Total
3.35M direct3.35M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.35M | Direct |
| Total | 3.35M | 3.35M direct |
Derivative Holdings2
Series B Warrants (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
224.72K
Shares owned
N/A
Exercise price
1.335
Expiration
—
Exercise window
—
Series C Warrants (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
687.69K
Shares owned
N/A
Exercise price
6.315
Expiration
—
Exercise window
—
Total
Underlying
912.41K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Warrants (right to buy) Direct | Common Stock | 1.335 | — | — | 224.72K | N/A |
| Series C Warrants (right to buy) Direct | Common Stock | 6.315 | — | — | 687.69K | N/A |
| Total | 912.41K | 0.00 | ||||